JP2020534326A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534326A5 JP2020534326A5 JP2020516662A JP2020516662A JP2020534326A5 JP 2020534326 A5 JP2020534326 A5 JP 2020534326A5 JP 2020516662 A JP2020516662 A JP 2020516662A JP 2020516662 A JP2020516662 A JP 2020516662A JP 2020534326 A5 JP2020534326 A5 JP 2020534326A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- immunoconjugate
- alkyl
- represented
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)N(*)C(C)(C1*)C1(C(C)(C)N(C(CC1*)=O)C1=O)[Rn] Chemical compound CC(C)N(*)C(C)(C1*)C1(C(C)(C)N(C(CC1*)=O)C1=O)[Rn] 0.000 description 8
- NIXKACOKLPRDMY-UHFFFAOYSA-N CC(CC(N1C)=O)C1=O Chemical compound CC(CC(N1C)=O)C1=O NIXKACOKLPRDMY-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022209534A JP2023036874A (ja) | 2017-09-22 | 2022-12-27 | イムノコンジュゲートにおけるメチオニン酸化を防止する方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762562049P | 2017-09-22 | 2017-09-22 | |
| US62/562,049 | 2017-09-22 | ||
| US201762573322P | 2017-10-17 | 2017-10-17 | |
| US62/573,322 | 2017-10-17 | ||
| US201862712584P | 2018-07-31 | 2018-07-31 | |
| US62/712,584 | 2018-07-31 | ||
| PCT/US2018/052197 WO2019060707A1 (en) | 2017-09-22 | 2018-09-21 | METHODS FOR PREVENTING OXIDATION OF METHIONINE IN IMMUNOCONJUGATES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022209534A Division JP2023036874A (ja) | 2017-09-22 | 2022-12-27 | イムノコンジュゲートにおけるメチオニン酸化を防止する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020534326A JP2020534326A (ja) | 2020-11-26 |
| JP2020534326A5 true JP2020534326A5 (cg-RX-API-DMAC10.html) | 2021-10-28 |
| JP7203834B2 JP7203834B2 (ja) | 2023-01-13 |
Family
ID=63794732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516662A Active JP7203834B2 (ja) | 2017-09-22 | 2018-09-21 | イムノコンジュゲートにおけるメチオニン酸化を防止する方法 |
| JP2022209534A Ceased JP2023036874A (ja) | 2017-09-22 | 2022-12-27 | イムノコンジュゲートにおけるメチオニン酸化を防止する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022209534A Ceased JP2023036874A (ja) | 2017-09-22 | 2022-12-27 | イムノコンジュゲートにおけるメチオニン酸化を防止する方法 |
Country Status (12)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100092T1 (it) * | 2015-06-29 | 2021-03-15 | Immunogen Inc | Anticorpi anti-cd123 e loro coniugati e derivati |
| JP7585231B2 (ja) * | 2019-04-29 | 2024-11-18 | イミュノジェン， インコーポレイテッド | 抗ｃｄ１２３免疫複合体を含む治療的組み合わせ |
| US20220251192A1 (en) * | 2019-06-26 | 2022-08-11 | Memorial Sloan Kettering Cancer Center | Anti-cd33 antibodies for treating cancer |
| WO2024222841A1 (zh) * | 2023-04-27 | 2024-10-31 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| WO2025064944A1 (en) * | 2023-09-20 | 2025-03-27 | Vor Biopharma Inc. | Anti-cd45 antibody-drug conjugate pharmaceutical compositions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| DK1578446T3 (en) | 2002-11-07 | 2015-06-29 | Immunogen Inc | ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT |
| US20100030670A1 (en) * | 2008-08-04 | 2010-02-04 | Mastercard International, Inc. | Method of monitoring different debit card transactions associated with a single funding source |
| EP2684570A1 (en) * | 2008-09-10 | 2014-01-15 | F. Hoffmann-La Roche AG | Compositions and methods for the prevention of oxidative degradation of proteins |
| JP2010241718A (ja) | 2009-04-03 | 2010-10-28 | Kyowa Hakko Kirin Co Ltd | 安定な抗体の水溶液製剤 |
| CN105777907B (zh) * | 2010-02-24 | 2020-03-17 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| AU2014229282B2 (en) | 2013-03-15 | 2017-02-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Low concentration antibody formulations |
| JP6517468B2 (ja) * | 2014-01-10 | 2019-05-22 | 日本電気株式会社 | 情報処理システム、情報処理装置、監視装置、監視方法、及び、プログラム |
| SMT202100092T1 (it) | 2015-06-29 | 2021-03-15 | Immunogen Inc | Anticorpi anti-cd123 e loro coniugati e derivati |
| RS65120B1 (sr) | 2015-11-25 | 2024-02-29 | Immunogen Inc | Farmaceutske formulacije i postupci za njihovu upotrebu |
-
2018
- 2018-09-21 CN CN201880075572.2A patent/CN111372610B/zh not_active Expired - Fee Related
- 2018-09-21 US US16/138,158 patent/US20190111147A1/en not_active Abandoned
- 2018-09-21 EP EP18783303.3A patent/EP3684412B1/en active Active
- 2018-09-21 CN CN202310589494.0A patent/CN117065043A/zh active Pending
- 2018-09-21 IL IL273384A patent/IL273384B2/en unknown
- 2018-09-21 KR KR1020207011137A patent/KR20200070254A/ko active Pending
- 2018-09-21 TW TW107133293A patent/TW201919711A/zh unknown
- 2018-09-21 MA MA050266A patent/MA50266A/fr unknown
- 2018-09-21 WO PCT/US2018/052197 patent/WO2019060707A1/en not_active Ceased
- 2018-09-21 JP JP2020516662A patent/JP7203834B2/ja active Active
- 2018-09-21 SG SG11202002116YA patent/SG11202002116YA/en unknown
- 2018-09-21 EP EP24156669.4A patent/EP4374850A2/en not_active Withdrawn
- 2018-09-21 CA CA3075896A patent/CA3075896A1/en active Pending
- 2018-09-21 AU AU2018335780A patent/AU2018335780A1/en not_active Abandoned
-
2021
- 2021-12-13 US US17/549,327 patent/US20220202947A1/en not_active Abandoned
-
2022
- 2022-12-27 JP JP2022209534A patent/JP2023036874A/ja not_active Ceased
-
2023
- 2023-07-18 IL IL304551A patent/IL304551A/en unknown
-
2024
- 2024-01-30 US US18/427,736 patent/US20240350652A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7447183B2 (ja) | 親水性抗体－薬物コンジュゲート | |
| ES2795818T3 (es) | Anticuerpos CD48 y conjugados de los mismos | |
| JP6310033B2 (ja) | 操作されたポリペプチドコンジュゲートおよびトランスグルタミナーゼを用いてそれを作製する方法 | |
| JP2022530524A5 (cg-RX-API-DMAC10.html) | ||
| JP6585600B2 (ja) | Ｃ末端軽鎖ポリペプチド伸長を含有する抗体、ならびにその複合体及びその使用方法 | |
| JP2021119199A (ja) | 抗体−薬物コンジュゲート凍結乾燥製剤 | |
| RU2019129839A (ru) | Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты | |
| CN117295526B (zh) | 制备工程化抗体的高度均质性抗体-药物偶联物的方法 | |
| JP7812359B2 (ja) | タイランスタチン類似体 | |
| AU2014372833A1 (en) | Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) | |
| HRP20230027T1 (hr) | Konjugati protutijela s lijekom i njihova upotreba u liječenju raka | |
| US20250127793A1 (en) | Conjugates of surrogate light chain constructs | |
| JP2023504187A5 (cg-RX-API-DMAC10.html) | ||
| JP7830555B2 (ja) | スルホマレイミドに基づくリンカーおよび対応する複合体 | |
| KR20180080128A (ko) | 항-ErbB2 항체-약물 접합체 및 그 조성물, 제조 방법 및 용도 | |
| JP2025503214A5 (cg-RX-API-DMAC10.html) | ||
| CN113121639B (zh) | 澳瑞他汀类似物及其偶联物、其制备方法及其应用 | |
| IL273384B2 (en) | Methods of preventing methionine oxidation in immunoconjugates | |
| JP2024504475A (ja) | 複合体およびその使用 | |
| RU2015106946A (ru) | Антитела к рецептору эндотелина типа в (etbr) и их иммуноконъюгаты | |
| RU2815199C2 (ru) | Линкеры на основе сульфомалеимида и соответствующие конъюгаты | |
| RU2023123071A (ru) | Способы предотвращения окисления метионина в иммуноконъюгатах | |
| WO2025227010A1 (en) | Protein tyrosine kinase 7 antibodies and antibody-drug conjugates | |
| WO2026092606A1 (zh) | 带有连接系统的抗体药物偶联物 | |
| JP2025081387A (ja) | ネクチン－４抗体及び抗体－薬物コンジュゲート |